XIFLAM
Dead / Abandoned — Abandoned — failure to respond (as of 27 Oct 2025)
What this means for you
This application is over — abandoned 14 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90747727
- Mark type
- Stylized text
- Filed
- 01 Jun 2021
- Published for opposition
- 22 Mar 2022
- Abandoned
- 14 Oct 2025
- Attorney of record
- Karen C. Kline
Goods and services
- Class 005 — Pharmaceuticals: Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of eye diseases and conditions
Owner
- OCUNEXUS THERAPEUTICS, INC., San Diego, CA, US
- OCUNEXUS THERAPEUTICS, INC., San Diego, CA, US
Prosecution history
- 27 Oct 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 27 Oct 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 11 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jul 2025 — NON-FINAL ACTION E-MAILED
- 11 Jul 2025 — SU - NON-FINAL ACTION - WRITTEN
- 02 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 18 May 2025 — USE AMENDMENT FILED
- 19 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 05 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2024 — SOU EXTENSION 5 GRANTED
- 15 Nov 2024 — SOU EXTENSION 5 FILED
- 15 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 29 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2024 — SOU EXTENSION 4 GRANTED
- 17 May 2024 — SOU EXTENSION 4 FILED